Post-systolic motion in patients with heart failure - A marker of left ventricular dyssynchrony?

European Journal of Echocardiography

Volumn 8, Issue 5, 2007, Pages 352-359

  Ring, Margareta ^a   Persson, Hans ^a   Mejhert, Märit ^b   Edner, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

Author keywords

Doppler tissue imaging; Heart failure; Post systolic motion

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MALE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX;

AGED; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548304503     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.07.006     Document Type: Article

References (33)

1. Stewart S., MacIntyre K., MacLeod M.M.C., Bailey A.E.M., Capewell S., and MacMurray J.J.V. Trends in hospitalisation for heart failure in Scotland, 1990-1996. Eur Heart J 22 (2001) 209-217
2. Reijtsma J.B., Mosterd A., de Craen A.J., Koster R.W., van Capelle F.J., De G., et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 76 (1996) 388-392
3. Schaufelberger M., Swedberg K., Köster M., Rosén M., and Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden. Eur Heart J 25 (2004) 300-307
4. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 283 (2000) 1295-1302
5. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., et al. Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 5 362 (2003) 7-13
6. Konstam M.A., Kronenberg M.W., Rousseau M.F., Udelson J.E., Melin J., Stewart D., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 88 (1993) 2277-2283
7. Vantrimpont P., Rouleau J.L., Wun C.C., Ciampi A., Klein M., Sussex B., et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. JACC 29 (1997) 229-236
8. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New Engl J Med 341 (1999) 709-717
9. Young J.B., Dunlap M.E., Pfeffer M.A., Probstfield J.L., Cohen-Solal A., Dietz R., et al. Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 110 (2004) 2618-2626
10. Garcia E.H., Perna E.R., Farias E.F., Obregon R.O., Macin S.M., Parras J.I., et al. Redused systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction: New insights in chronic heart failure. Int J Cardiol 108 2 (2006) 181-188
11. Jarnert C., Mejhert M., Ring M., Persson H., and Edner M. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail 2 (2000) 151-160
12. Bradley D.J., Bradley E.A., Baughman K.L., Berger R.D., Calkins H., Goodman S.N., et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 289 (2003) 730-740
13. Bax J.J., Ansalone G., Breithardt O.A., Derumeaux G., Leclercq C., Schalij M.J., et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. JACC 44 (2004) 1-9
14. Sogaard P., Kim W.Y., Jensen H.K., Mortensen P., Pedersen A.K., Kristensen B.O., et al. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue doppler and three-dimensional echocardiographic study. Cardiology 95 (2001) 173-182
15. Yu C.-M., Chau E., Sanderson J.E., Fan K., Tang M.-O., Fung W.-H., et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105 (2002) 438-445
16. Doyle R.L., Foex P., Ryder W.A., and Jones L.A. Differences in ischaemic dysfunction after gradual and abrupt coronary occlusion: effects on isovolumic relaxation. Cardiovasc Res 21 (1987) 507-514
17. Hosokawa H., Sheehan F.H., and Suzuki T. Measurement of postsystolic shortening to assess viability and predict recovery of left ventricular function after acute myocardial infarction. JACC 35 (2000) 1842-1849
18. Palmon L.C., Reichek N., Yeon S.B., Clark N.R., Brownson D., Hoffman E., et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 89 (1994) 122-131
19. Voigt J.U., Lindenmeier G., Exner B., Regenfus M., Werner D., Reulbach U., et al. Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc Echocardiogr 16 (2003) 415-423
20. Jamal F., Kukulski T., D'hooge J., De Scheerder I., and Sutherland G. Abnormal postsystolic thickening in acutely ischemic myocardium during coronary angioplasty: a velocity, strain, and strain rate doppler myocardial imaging study. J Am Soc Echocardiogr 12 (1999) 994-996
21. Galderisi M., Cicala S., Sangiorgi G., Caso P., and de Divitiis O. Tissue Doppler-derived postsystolic motion in a patient with left bundle branch block: a sign of myocardial wall asynchrony. Echocardiography 19 (2002) 79-81
22. Mejhert M., Kahan T., Persson H., and Edner M. Limited long term effects of management program for heart failure. Heart 90 (2004) 1010-1015
23. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. American Society of Echocardiography Committee on standards, Subcommittee on quantification of two-dimensional echocardiography. Recommendations for quantifications of the left ventricle by two-dimension echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
24. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
25. Ry D.S., Clerico A., Giannessi D., Andreassi M.G., Capriolli R., Iascone M.R., et al. Measurements of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an IRMA method. Scand J Clin Lab Invest 60 (2000) 81-90
26. Skulstad H., Edvardsen T., Urheim S., Rabben S.I., Stugaard M., Lyseggen E., et al. Postsystolic shortening in ischemic myocardium: active contraction or passive recoil?. Circulation 106 (2002) 718-724
27. Citro R., Galderisi M., Guaini P., Cicala S., Mattioli D., Bianco A., et al. Left bundle branch block with and without coronary artery disease: which value for a tissue Doppler-derived post-systolic motion. Ital Heart J 4 (2003) 706-712
28. Gorscan J., Kanzaki H., Bazaz R., Dohi K., and Schwartman D. Usefulness of echocardiographic tissue synchronisation imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1178-1181
29. Yu C.M., Zhang Q., Fung J.W., Chang H.C., Chan Y.S., Yip G.W., et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. JACC 45 (2005) 677-684
30. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., et al. Plasma brain natriuetric peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
31. McCullogh P.A., Nowak R.M., McCord J., Hollander J.E., Herrman H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
32. Giannuzzi P., Temporelli P.L., Bosimini E., Silva P., Imparato A., Corra U., et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. JACC 28 (1996) 283-390
33. Juilliere Y., Barbier G., Feldmann L., Grentzinger A., Danchin N., and Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 18 (1997) 276-280